Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 828

1.

Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.

Tekle WG, Chaudhry SA, Hassan AE, Peacock JM, Lakshminarayan K, Tsai A, Luepker R, Anderson DC, Qureshi AI.

Cerebrovasc Dis. 2012;34(5-6):400-5. doi: 10.1159/000343504. Epub 2012 Dec 4.

PMID:
23221276
2.

Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.

Williams JM, Navin TJ, Jude MR, Levi CR.

Aust J Rural Health. 2013 Aug;21(4):203-7. doi: 10.1111/ajr.12038.

PMID:
24033520
3.

MRI-based ultrafast protocol thrombolysis with rt-PA for acute ischemia stroke in 12-hour time window.

Li YH, Li MH, Zhao JG, Wang W.

J Neuroimaging. 2011 Oct;21(4):332-9. doi: 10.1111/j.1552-6569.2010.00544.x. Epub 2010 Dec 1.

PMID:
21121996
4.

Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.

Romano JG, Smith EE, Liang L, Gardener H, Camp S, Shuey L, Cook A, Campo-Bustillo I, Khatri P, Bhatt DL, Fonarow GC, Sacco RL, Schwamm LH.

JAMA Neurol. 2015 Apr;72(4):423-31. doi: 10.1001/jamaneurol.2014.4354.

PMID:
25642650
7.

Feasibility and outcomes of intravenous thrombolysis 3-4.5 hours after stroke in Chinese patients.

Xu ZP, Li HH, Li YH, Zhang Y, Wu Q, Lin L.

J Clin Neurosci. 2014 May;21(5):822-6. doi: 10.1016/j.jocn.2013.08.014. Epub 2013 Oct 19.

PMID:
24444672
8.

Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.

García-Bermejo P, Calleja AI, Pérez-Fernández S, Cortijo E, del Monte JM, García-Porrero M, Fe Muñoz M, Fernández-Herranz R, Arenillas JF.

Cerebrovasc Dis. 2012;34(1):31-7. doi: 10.1159/000338778. Epub 2012 Jun 29.

PMID:
22759450
9.

Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?

Hassan AE, Chaudhry SA, Jani V, Grigoryan M, Khan AA, Adil MM, Qureshi AI.

J Stroke Cerebrovasc Dis. 2013 May;22(4):545-9. doi: 10.1016/j.jstrokecerebrovasdis.2013.01.022. Epub 2013 Feb 28.

PMID:
23453555
10.

[Prerequisites, indications and contraindications of IV-lysis of ischemic stroke with rt-PA].

Marx P, Hartmann A, Leistner S, Nohr R, Koennecke HC.

Fortschr Neurol Psychiatr. 2001 Aug;69(8):346-52. German.

PMID:
11584683
11.

Outcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: initial experience of a community-based hospital in a developing country.

Muengtaweepongsa S, Dharmasaroja P, Kummark U.

J Stroke Cerebrovasc Dis. 2012 Jan;21(1):42-6. doi: 10.1016/j.jstrokecerebrovasdis.2010.03.017. Epub 2010 Jun 17.

PMID:
22225863
12.

Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.

California Acute Stroke Pilot Registry (CASPR) Investigators.

Neurology. 2005 Feb 22;64(4):654-9.

PMID:
15728287
13.

[Implementation of thrombolysis in acute stroke--10-year results of the Innsbruck stroke registry].

Matosević B, Zangerle A, Furtner M, Knoflach M, Werner P, Prantl B, Wille G, Illmer A, Mair A, Spiegel M, Schmidauer C, Sojer M, Muigg A, Willeit J, Kiechl S.

Wien Klin Wochenschr. 2009;121(23-24):750-6. doi: 10.1007/s00508-009-1201-z. German.

PMID:
20047113
14.

The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.

Kahn JH, Viereck J, Kase C, Jeerakathil T, Romero R, Mehta SD, Kociol R, Babikian V.

J Emerg Med. 2005 Oct;29(3):273-7.

PMID:
16183445
15.

Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?

Fang K, Churilov L, Weir L, Dong Q, Davis S, Yan B.

J Stroke Cerebrovasc Dis. 2014 Mar;23(3):427-32. doi: 10.1016/j.jstrokecerebrovasdis.2013.03.029. Epub 2013 Apr 28.

PMID:
23635920
16.

Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.

Salam KA, Ummer K, Pradeep Kumar VG, Noone ML.

Int J Stroke. 2014 Jun;9(4):426-8. doi: 10.1111/ijs.12128. Epub 2013 Aug 26.

PMID:
23981667
17.

Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.

Schwammenthal Y, Drescher MJ, Merzeliak O, Tsabari R, Bruk B, Feibel M, Hoffman C, Bakon M, Rotstein Z, Chapman J, Tanne D.

Isr Med Assoc J. 2004 Feb;6(2):70-4.

18.

Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.

Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.

J Stroke Cerebrovasc Dis. 2013 Apr;22(3):190-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.016. Epub 2011 Oct 2.

PMID:
21968092
20.

Intravenous tissue plasminogen activator for patients with minor ischemic stroke.

Huisa BN, Raman R, Neil W, Ernstrom K, Hemmen TM.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):732-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.03.009. Epub 2011 Apr 30.

Supplemental Content

Support Center